An insight into the prevalence of NAFLD and NASH. Prof Abdelmalek, USA

Play Video

Prevalence of NAFLD (non-alcoholic fatty liver disease) affects approximately 25% of the entire US population. Of that, approximately six to eight percent may have Non-Alcoholic Steatohepatitis or NASH and thus this is the cohort of patients that have an increased risk for developing complications of end-stage liver disease over time or are also at risk of developing cardiovascular morbidity and mortality.

Would you like to read more?

Prof. M. F. Abdelmalek

Prof. M. F. Abdelmalek

Manal F. Abdelmalek, MD, MPH is Director of Hepatology and institutional lead for investigator-initiated and industry-sponsored multicenter clinical studies, Mayo Clinic, USA. Until recently, she was tenured Professor of Medicine in the Division of Gastroenterology and Hepatology at...



Subscribe Our Newsletter To Get the Lastest Updates